Potassium guaiacolsulfonate

DB13735ApprovedWithdrawnSmall molecule

Potassium guaiacolsulfonate is a mucolytic and expectorant indicated to relieve a productive cough. Guaiacolsulfonate is an aromatic sulfonic acid.

First approval: Canada, 2001
Also known as: Guaiacolsulfonate potassium · Potassium sulfoguaiacolate

Resolves to

Compound

UNII21A795TNZDCAS1321-14-8

Clinical / RWD

RxNorm91275

What you can answer from here — as of April 02, 2025

289Drug interactionsStructured to mechanism, not free text

6Structured indicationsCondition, population, route and combination as fields, not prose

19ContraindicationsEach with its own population and attribute set

33Marketed productsAcross 6 countries and 24 labellers

1+ReferenceStructured and connected to the statements they support

Which other approved drugs treat the same conditions as Potassium guaiacolsulfonate, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account